Long-Term Risk of Clinically Significant Prostate Cancer in Biopsy-Negative Patients With Baseline Biparametric Prostate MRI.

ABSTRACT:

Background

The long-term prevalence of clinically significant prostate cancer (csPCa) in patients with initial negative prostate biopsy is unknown.

Purpose

To investigate the rate of csPCa of men with initial negative biopsy.

Study type

Retrospective analysis of prospectively collected data.

Population

A total of 197 men (mean age 63 years [SD ±6.98, range 29-79]) without csPCa on initial biopsy and available baseline biparametric prostate MRI (bpMRI).

Field strength/sequence

3.0 T, turbo spin-echo T2-weighted (axial and sagittal) and three sets of diffusion-weighted imaging using single-shot spin-echo planar imaging (5 b-values 0-500 seconds/mm²; 2 b-values 0 and 1500 seconds/mm², and 2 b-values 0 and 2000 seconds/mm²).<

SUBMITTER: Parhiala L 

PROVIDER: S-EPMC12063762 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature